Srinivas Tallapragada - Jun 5, 2023 Form 4 Insider Report for Salesforce, Inc. (CRM)

Signature
/s/ Ariel Gaknoki, Attorney-in-Fact for Srinivas Tallapragada
Stock symbol
CRM
Transactions as of
Jun 5, 2023
Transactions value $
-$13,493,742
Form type
4
Date filed
6/6/2023, 04:26 PM
Previous filing
Apr 24, 2023
Next filing
Jun 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRM Common Stock Options Exercise $7.25M +61.5K +109.82% $118.04 117K Jun 5, 2023 Direct
transaction CRM Common Stock Options Exercise $10.9M +88.9K +75.7% $122.82 206K Jun 5, 2023 Direct
transaction CRM Common Stock Sale -$2.11K -10 0% $210.63 206K Jun 5, 2023 Direct
transaction CRM Common Stock Sale -$31.7M -150K -72.87% $210.62 56K Jun 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -61.5K -100% $0.00* 0 Jun 5, 2023 Common Stock 61.5K $118.04 Direct F2
transaction CRM Non-qualified Stock Option (Right to Buy) Options Exercise $0 -88.9K -100% $0.00* 0 Jun 5, 2023 Common Stock 88.9K $122.82 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Weighted average price. These shares were sold in multiple transactions at prices ranging from $210.0200 to $211.2500 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F2 Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.
F3 Option is exercisable and vests over four years at the rate of 25% on April 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.